Literature DB >> 15279070

Meal intake similarly reduces circulating concentrations of octanoyl and total ghrelin in humans.

P Lucidi1, G Murdolo, C Di Loreto, N Parlanti, A De Cicco, A Ranchelli, C Fatone, C Taglioni, C Fanelli, F Santeusanio, P De Feo.   

Abstract

UNLABELLED: ABSTRACT. Several data show that meal intake and nutritional status regulate circulating ghrelin concentrations in humans. Ghrelin mainly circulates in two different forms: octanoyl and des-octanoyl ghrelin. Most circulating ghrelin is des-octanoyl ghrelin which is considered inactive because it lacks endocrine activity. However, recent evidence suggests that des-octanoyl ghrelin exerts biological activity such as stimulation of adipogenesis, cardiovascular effects and control of cell growth. In healthy humans, although the total ghrelin concentration is known to peak before meals and to be reduced by food intake, no data are available about the octanoyl ghrelin response in the absorptive state. Therefore, after an overnight fast, we compared the effects of a mixed meal ingestion (meal study) or of additional 240 min fasting (control study) on plasma concentrations of octanoyl and total ghrelin in 6 healthy subjects (body mass index: 23 +/- 0.7). At baseline, octanoyl-ghrelin accounted for 3.15 +/- 0.2% of total circulating ghrelin without differences between the two sessions. A similar ratio was maintained in the absorptive state with no differences between the studies and basal values. Compared with control, meal intake significantly suppressed (nadir at 90 min) octanoyl and total ghrelin by 38 +/- 3 and 40 +/- 3% of basal values, respectively. In the meal study, multivariate analysis of variance showed that serum insulin best predicted plasma octanoyl-ghrelin concentrations accounting for 97% of its variation (r2 = -0.97,p = 0.0016). IN
CONCLUSION: in healthy humans, octanoyl-ghrelin represents about 3-4% of total circula-ting ghrelin and this ratio is closely maintained in post-absorptive and absorptive states.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15279070

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase.

Authors:  W Arlt; R J Auchus; W L Miller
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

2.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

3.  Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells in vitro.

Authors:  Johannes D Veldhuis; George Zhang; James C Garmey
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

Review 4.  Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator.

Authors:  S Rocchi; J Auwerx
Journal:  Ann Med       Date:  1999-10       Impact factor: 4.709

5.  Troglitazone: a possible modulator of ovarian steroidogenesis.

Authors:  Mohamed F M Mitwally; Selma F Witchel; Robert F Casper
Journal:  J Soc Gynecol Investig       Date:  2002 May-Jun

6.  Rosiglitazone.

Authors:  B J Goldstein
Journal:  Int J Clin Pract       Date:  2000-06       Impact factor: 2.503

7.  Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.

Authors:  Anthony P Heaney; Manory Fernando; William H Yong; Shlomo Melmed
Journal:  Nat Med       Date:  2002-10-15       Impact factor: 53.440

8.  PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

Authors:  Anthony P Heaney; Manory Fernando; Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

9.  Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

Authors:  T Kubota; K Koshizuka; E A Williamson; H Asou; J W Said; S Holden; I Miyoshi; H P Koeffler
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

10.  Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.

Authors:  Steven M Willi; Adele Kennedy; Penny Wallace; Elizabeth Ganaway; Nikki L Rogers; W Timothy Garvey
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

View more
  8 in total

1.  Twenty-four-hour profiles of acylated and total ghrelin: relationship with glucose levels and impact of time of day and sleep.

Authors:  Karine Spiegel; Esra Tasali; Rachel Leproult; Neal Scherberg; Eve Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  2010-11-24       Impact factor: 5.958

2.  The effects of exercise on food intake and hunger: relationship with acylated ghrelin and leptin.

Authors:  Serife Vatansever-Ozen; Gul Tiryaki-Sonmez; Guler Bugdayci; Guclu Ozen
Journal:  J Sports Sci Med       Date:  2011-06-01       Impact factor: 2.988

Review 3.  Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.

Authors:  Hua Jin; Jonathan M Meyer; Sunder Mudaliar; Dilip V Jeste
Journal:  Schizophr Res       Date:  2008-01-18       Impact factor: 4.939

4.  The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study.

Authors:  Inmaculada Baeza; Laura Vigo; Elena de la Serna; Rosa Calvo-Escalona; Jessica Merchán-Naranjo; Pamela Rodríguez-Latorre; Celso Arango; Josefina Castro-Fornieles
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-05-21       Impact factor: 4.785

5.  Euglycemic hyperinsulinemia differentially modulates circulating total and acylated-ghrelin in humans.

Authors:  M O Weickert; C V Loeffelholz; A M Arafat; C Schöfl; B Otto; J Spranger; M Möhlig; A F Pfeiffer
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

6.  Effects of meals high in carbohydrate, protein, and fat on ghrelin and peptide YY secretion in prepubertal children.

Authors:  Jefferson P Lomenick; Maria S Melguizo; Sabrina L Mitchell; Marshall L Summar; James W Anderson
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

Review 7.  Regulation of Postabsorptive and Postprandial Glucose Metabolism by Insulin-Dependent and Insulin-Independent Mechanisms: An Integrative Approach.

Authors:  George D Dimitriadis; Eirini Maratou; Aikaterini Kountouri; Mary Board; Vaia Lambadiari
Journal:  Nutrients       Date:  2021-01-06       Impact factor: 5.717

8.  Visual stimulation with food pictures in the regulation of hunger hormones and nutrient deposition, a potential contributor to the obesity crisis.

Authors:  Kalina Duszka; András Gregor; Martin Willibald Reichel; Andreas Baierl; Christine Fahrngruber; Jürgen König
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.